Conor Medsystems Inc v Angiotech Pharmaceuticals Inc

Obviousness is judged by reference to the claim, not the specification, and a patent need not show that the invention works, as long as it is not obvious to try.

Citation
[2008] UKHL 49, [2008] RPC 28
Court
House of Lords
Year
2008
Subject
Intellectual Property Law
Topic
Patents: patentability and validity

Facts

Angiotech held a patent for a stent, a device used to keep arteries open, coated with taxol, a drug, to prevent the artery from narrowing again. Conor challenged the patent's validity, arguing that it was obvious to try taxol as a coating, because it was one of a number of possible drugs, and that the patent did not show that taxol would work.

Legal principle

The House of Lords held that the patent was valid. Lord Hoffmann said that the question of obviousness must be considered in relation to the invention as claimed, which was a stent coated with taxol, and that the question was whether it was obvious to use taxol, not whether it was obvious that it would work. It was not enough that it was obvious to try taxol among many possible candidates, unless there was a reasonable expectation of success. A patent does not need to demonstrate by evidence that the invention works, as long as it is plausible.

Related cases on patents: patentability and validity

Studying intellectual property law? Our tutors help you understand and apply cases like this in essays, problem questions and exams. Request a quote or browse our law notes.

Back to all law cases

This summary is for study and revision and is not legal advice. Although our case summaries are checked for accuracy, we do not guarantee that they are free from errors or omissions. Always read the full judgment for the court's reasoning.

Contact Us

Enquire about our bespoke academic solutions